260 related articles for article (PubMed ID: 30721454)
41. Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.
Wildes TM; Anderson KC
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):88-96. PubMed ID: 30504296
[TBL] [Abstract][Full Text] [Related]
42. Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone.
Sato S; Kambe E; Tamai Y
Intern Med; 2019 Mar; 58(6):843-847. PubMed ID: 30449801
[TBL] [Abstract][Full Text] [Related]
43. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
Bouchet A; Teuma C; Nouvier M; Rousset P; Javaugue V; Lazareth A; Lombard C; Isaac S; Fouque D
Am J Kidney Dis; 2019 Nov; 74(5):700-702. PubMed ID: 31155325
[TBL] [Abstract][Full Text] [Related]
44. Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.
Zhou DB; Yu L; Du X; Jin J; Cai Z; Chen F; Ke X; Li X; Wu D; Meng F; Ai H; Zhang J; DeMarco D; Chen N; Mei J; Wang J; Hou J
Int J Hematol; 2015 Jun; 101(6):569-77. PubMed ID: 25753225
[TBL] [Abstract][Full Text] [Related]
45. Crystalline cast nephropathy in a patient with IgD lambda myeloma.
Kumakura S; Nakaya I; Sakuma T; Sato H; Soma J
Clin Exp Nephrol; 2016 Jun; 20(3):491-2. PubMed ID: 26515717
[No Abstract] [Full Text] [Related]
46. [Successful steroid therapy for indolent myeloma with kidney injury due to direct infiltration of myeloma cells].
Tanaka T; Maeda Y
Nihon Jinzo Gakkai Shi; 2015; 57(7):1241-7. PubMed ID: 26665616
[TBL] [Abstract][Full Text] [Related]
47. Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
Shibata S; Fukunaga A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257362
[TBL] [Abstract][Full Text] [Related]
48. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
Nockowski P; Woźniak Z; Reich A; Maj J
Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
[TBL] [Abstract][Full Text] [Related]
49. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
[TBL] [Abstract][Full Text] [Related]
50. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma.
Qian Q; Leung N; Theis JD; Dogan A; Sethi S
Am J Kidney Dis; 2010 Nov; 56(5):971-6. PubMed ID: 20870327
[TBL] [Abstract][Full Text] [Related]
51. Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma.
Mathur M; Chacko B; Vankalakunti M; Patil C
Saudi J Kidney Dis Transpl; 2016; 27(4):805-7. PubMed ID: 27424703
[TBL] [Abstract][Full Text] [Related]
52. [Safety and effectiveness of low-dose lenalidomide therapy for multiple myeloma complicated with bortezomib-associated interstitial pneumonia].
Nagamachi Y; Yamauchi N; Muramatsu H; Okamoto T; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Tanaka S; Ono K; Kikuchi S; Kato J
Rinsho Ketsueki; 2013 May; 54(5):451-6. PubMed ID: 23727683
[TBL] [Abstract][Full Text] [Related]
53. A monoclonal V kappa l light chain responsible for incomplete proximal tubulopathy.
Decourt C; Bridoux F; Touchard G; Cogné M
Am J Kidney Dis; 2003 Feb; 41(2):497-504. PubMed ID: 12552516
[TBL] [Abstract][Full Text] [Related]
54. [Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients].
Okazuka K; Ishida T; Sato K; Miyazaki K; Yoshiki Y; Abe Y; Tsukada N; Suzuki K
Rinsho Ketsueki; 2018; 59(6):698-700. PubMed ID: 29973446
[TBL] [Abstract][Full Text] [Related]
55. [Loss of CD23 expression after bortezomib plus dexamethasone therapy in CCND1/IGH-positive multiple myeloma].
Fujimi A; Hashimoto A; Kanisawa Y; Okuda T; Minami S; Doi T; Matsuno T; Ishikawa K; Uemura N
Rinsho Ketsueki; 2013 Feb; 54(2):224-8. PubMed ID: 23470832
[TBL] [Abstract][Full Text] [Related]
56. V-domain deposition of lambda Bence Jones protein in the renal tubular epithelial cells in a patient with the adult Fanconi syndrome with myeloma.
Isobe T; Kametani F; Shinoda T
Amyloid; 1998 Jun; 5(2):117-20. PubMed ID: 9686306
[TBL] [Abstract][Full Text] [Related]
57. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
Cohen C; Royer B; Javaugue V; Szalat R; El Karoui K; Caulier A; Knebelmann B; Jaccard A; Chevret S; Touchard G; Fermand JP; Arnulf B; Bridoux F
Kidney Int; 2015 Nov; 88(5):1135-43. PubMed ID: 26176826
[TBL] [Abstract][Full Text] [Related]
58. Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria.
Harder H; Eucker J; Zang C; Possinger K; Müller-Höcker J; Beutler E; Petrides PE
Ann Hematol; 2000 Nov; 79(11):640-3. PubMed ID: 11131925
[TBL] [Abstract][Full Text] [Related]
59. Non-crystalline light chain proximal tubulopathy without renal Fanconi syndrome in a patient with IgD-λ multiple myeloma.
Ikeda D; Matsue K
Br J Haematol; 2022 Jan; 196(2):261. PubMed ID: 34472090
[No Abstract] [Full Text] [Related]
60. Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone.
Shin J; Lee JJ; Kim K; Min CK; Lee JO; Suh C; Kim JS; Lee YJ; Yoon SS; Jo JC; Lee HS; Bang SM;
Int J Hematol; 2019 Jan; 109(1):79-90. PubMed ID: 30291558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
